Press Releases
GSK and Vir Biotechnology announce US government agreement to purchase additional supply of sotrovimab, authorised for the early treatment of COVID-19
GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the US Government will purchase an additional 600,000 doses of sotrovimab, an investigational monoclonal antibody for the early treatment of COVID-19, enabling further nationwide access to sotrovimab for patients. The additional...
Drug Research
Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes for Oncology
Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Carisma Therapeutics Inc., a biopharmaceutical pioneer in engineered macrophage-based therapeutics, today announced that the two companies have entered into a strategic collaboration agreement to discover, develop...
Drug Research
Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine
Pfizer Inc. and BioNTech SE announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles (herpes zoster virus, or HZV), a debilitating, disfiguring and painful disease that impacts about...
Press Releases
Synairgen announces global strategic partnership with Ashfield Engage
Synairgen plc, the respiratory company developing SNG001 (inhaled interferon-beta or IFN-beta) for the treatment of COVID-19 as potentially the first host-targeted, broad-spectrum antiviral treatment delivered directly into the lungs, today announces a partnership with global experts in strategic engagement...
Press Releases
CPhI predictions for 2022: high manufacturing demand to constrain global ingredients, partnering options and available CDMO capacity
CPhI Worldwide releases its beginning of year pharma market predictions for 2022 combining research from over 350 pharma executives and expert views from 10 CPhI contributors.
The findings suggest that there will be 30+ FDA new drug approvals in the...
Press Releases
Moderna Announces Supply Agreement with South Korea for Additional 20 Million Doses of COVID-19 Vaccine in 2022
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a revised supply agreement with the government of South Korea for 20 million doses of Moderna's COVID-19 vaccine or an updated booster vaccine candidate, if authorized....
Packaging & Labelling
Togg goes international on the wings of Turkish Airlines
Global air cargo brand Turkish Cargo became the logistics solutions partner of Togg (Turkey's Automobile Joint Venture Group), which was founded with the mission of becoming Turkey's most valuable global mobility brand. National brand carries Turkey's first electric automobile...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















